Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Belvidere › NPI 1407872591
Physician

Englund, Karen

Englund, Karen was paid $356K by Medicaid between Jan 2018 and Mar 2024, across 10 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 48% of everything it billed.

33Billing provider infoENGLUND, KAREN
BELVIDERE, IL 61008
33aNPI1407872591assigned 07/14/2006
28Total paid$356K
24GClaims7,494
24DCodes billed10
24AFirst – last monthJan 2018 – Mar 2024
Compared with peers

Next to other Family Medicine Physician providers in Illinois

Rank by total paid#302 of 2,947
Median peer was paid$43K
This provider vs. median8.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,113$46K
20192,335$118K
20201,373$56K
2021873$43K
2022840$43K
2023830$43K
2024incomplete130$7K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 48% 2,764 2,543 $170K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 48% 4,102 3,786 $169K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.2% 132 103 $4K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity <1% 81 73 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 145 137 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 87 72 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 24 24 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 54 51 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 13 13 $667.03
81002 <1% 92 83 $237.65

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.